SCHEMBL21667179

SCHEMBL21667179

CC(C)n1c(=O)[nH]c(NCc2cccc(F)c2)c(F)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.44
▸ GPR84 Q9NQS5 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ DAO P14920 1/20 0.38
▸ FFAR1 O14842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667303 0.88 PDE9A (0.46) PGRGPR84MAPTLMNATP53
SCHEMBL21667314 0.88 CDK1 (0.44) ALDH1A1GAAKDM4ECYP3A4MAPT
SCHEMBL21667181 0.86 PDE9A (0.48) ALDH1A1MAPTTSHRDAO
SCHEMBL21667176 0.80 CYP3A4 (0.49) PGRGPR84ALDH1A1HPGDGAA
SCHEMBL22367979 0.78 SMN1; SMN2 (0.46) GPR84KDM4ECYP3A4MAPTLMNA
SCHEMBL16322100 0.77 CYP3A4 (0.46) PGRCYP3A4HTT
SCHEMBL30509657 0.77 CYP3A4 (0.46) PGRCYP3A4HTT
SCHEMBL16322101 0.77 CYP3A4 (0.46) PGRCYP3A4HTT
SCHEMBL21667336 0.76 CDK1 (0.45) ALDH1A1GAAKDM4ECYP3A4MAPT
SCHEMBL21667316 0.73 CDK1 (0.44) ALDH1A1GAAKDM4ECYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3702352-A1 PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS Myokardia, Inc. (US) 2020-09-02 — — EP disclosed
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback